Olamide (Metoclopramide Hydrochloride)

Metoclopramide Hydrochloride, the active ingredient in Olamide, is a dopamine‑D2 receptor antagonist presented as a tablet for oral use. It is employed to accelerate gastric emptying and to control nausea and vomiting in adult patients. GNH USA supplies Olamide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olamide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide is indicated for disorders affecting gastrointestinal motility and for nausea and vomiting. - Diabetic gastroparesis: improves gastric emptying and reduces related symptoms. - Chemotherapy‑induced nausea and vomiting: helps prevent and control acute episodes. - Post‑operative nausea and vomiting: reduces the incidence of nausea after surgery. - Migraine‑associated nausea: allevi tablet of nausea in migraine attacks. - Functional dyspepsia: eases early satiety and post‑prandial fullness.

Metoclopide   

Common   def  t  

Metocidi  t